Innovation is the life blood of any pharmaceutical or BioTech Company. The complexities intrinsic to the drug lifecycle, combined with meeting global quality and regulatory compliance requirements presents a challenging innovation environment for these companies to meet the needs of their patients and drive competitive advantage.
Dassault Systèmes can help you proactively manage this complexity; delivering digital continuity to transform the way your pharmaceutical company operates.
Dassault Systèmes 3DEXPERIENCE platform transforms the way “innovators innovate with patients” by connecting designers, engineers, marketers, and even patients in a new ‘social enterprise’. We will share how Dassault Systèmes can enable patient centric innovation in a new digital model paradigm, turning data into insight, accelerating decision-making, and optimizing change implementation. A live Q&A session will take place at the end of the presentation.
Jean Colombel, VP Life Sciences Industry, Dassault Systèmes
Kevin O’Leary, Head of Quality, Regulatory and Compliance Solutions, Dassault Systèmes